Therapeutic Drug Monitoring
|
Mixed function oxidase (MFO) system
|
Biochemical pathway responsible for the greatest portion of drug metabolism
|
Intravenous route
|
100% bioavailability
|
Liberation
|
Drug à Release
|
Absorption
|
Drug à Blood (most: by passive diffusion)
|
Distribution
|
Drug à Tissues
|
Metabolism
|
Drug à Chemical modification
|
Excretion
|
Drug à metabolites à excreted
|
Bioavailable fraction (f)
|
Fraction of the dose that reaches the blood
|
Vd of a drug
|
Dilution of the drug after it has been distributed in the body
|
First-pass hepatic metabolism
|
Drugs à Liver à Decreased bioavailability
|
First order elimination
|
Linear relationship bet. the amt. of drug eliminated per hour and the blood level of drug
|
Pharmacodynamics
|
Relationship bet. drug concentration at the target site and response of the tissues
|
Pharmacokinetics
|
Relationship bet. drug dose and drug blood level
|
Pharmacogenomics
|
Study of genes that affect the performance of a drug in an individual
|
Therapeutic index
|
Ratio bet. the minimum toxic and maximum therapeutic serum conc.
|
Trough concentration
|
Lowest concentration of a drug obtained in the dosing interval
Drawn immediately (or 30 mins) before the next dose
|
Peak concentration
|
Highest concentration of a drug obtained in the dosing interval
Drawn one hour after an orally administered dose (except digoxin)
|
Cardioactive Drugs
|
Class I
|
Rapid Na+ channel blockers (Procainamide, Lidocaine, Quinidine)
|
Class II
|
Beta receptor blockers (Propanolol)
|
Class III
|
K+ channel blockers (Amiodarone)
|
Class IV
|
Ca2+ channel blockers (Verapamil)
|
Digoxin
|
Tx: CHF
|
Lidocaine (Xylocaine)
|
Local anesthetic
1’ product of hepatic metabolism: MEGX (monoethylglycinexylidide)
|
Quinidine
|
Common formulations: Quinidine sulfate and Quinidine gluconate
|
Procainamide (Pronestyl)
|
Hepatic metabolite: NAPA (N-acetylprocainamide)
Toxic effect: reversible lupus-like syndrome
|
Disopyramide
|
Substitute for quinidine
Anticholinergic effects
|
Propanolol
|
Tx: angina pectoris
|
Amiodarone (Cordarone)
|
Iodine-containing drug
|
Verapamil
|
Tx: angina, hypertension, supraventricular arrhythmias
|
Antibiotics
|
Aminoglycosides
|
Tx: Gram (-) bacterial infections
Nephrotoxic and ototoxic
|
Vancomycin
|
Tx: Gram (+) cocci and bacilli
Toxic effects:
“Red man syndrome”
Nephrotoxic and ototoxic
|
Antiepileptic Drugs
|
Phenobarbital
|
Long acting barbiturate
Enhances bilirubin metabolism
Inactive proform: Primidone
|
Phenytoin (Dilantin)
|
Injectable proform: fosphenytoin
|
Valproic acid (Depakene)
|
Tx: petit mal and grand mal
|
Carbamazepine (Tegretol)
|
Tx: grand mal
|
Ethosuximide (Zarontin)
|
Drug of choice for controlling petit mal seizure
|
Gabapentin (Neurontin)
|
Similar to neurotransmitter GABA
|
Others (Antiepileptic)
|
Topiramate
Lamotrigine (Lamictal)
Felbamate
|
Psychoactive Drugs
|
Lithium
|
Tx: Bipolar disorders (Manic depression)
|
Tricyclic antidepressantas (TCA)
|
Imipramine
Amitriptyline
Doxepin
Nortriptyline
Tradazone
|
|
Major metabolite: Desipramine
|
Fluoxetine (Prozac)
|
Blocks reuptake of serotonin
Tx: Obsessive-compulsive disorders
|
Bronchodilator
|
Theophylline
|
Tx: Asthma and other COPD
|
Anti-inflammatory and Analgesic Drugs
|
Salicylates/Aspirin (Acetylsalicylic acid)
|
Antiplatelet (inhibits cyclooxygenase)
Method: Trinder assay
|
Acetaminophen (Tylenol)
|
Hepatotoxic
|
Ibuprofen
|
Lower risk of toxicity than salicylates and acetaminophen
|
Neuroleptics (Antipsychotic major tranquilizers)
|
Neuroleptics
|
Block the action of dopamine and serotonin
Tx: Schizophrenia
2 classes:
-Phenothiazines (chlorpromazine)
-Butyrophenones (haloperidol)
Examples:
-Risperdal
-Olonzapine (Zyprexa)
-Quetiapine (Seroquel)
-Aripiprazole (Abilify)
|
Immunosuppressants
|
Cyclosporine
Tacrolimus (FK-506)
Rapamycin (Sirolimus)
Mycophenolate mofetil
Lefluamide
|
Chemotherapeutic agents
|
Busulfan
Methotrexate
|
Toxicology
|
Toxic Agents
|
Alcohols (%w/v)
|
Common CNS depressants
|
0.01-0.05
|
No obvious impairment, some changes observable on performance testing
|
0.03-0.12
|
Mild euphoria, decr. inhibitions, some impairment of motor skills
|
0.09-0.25
|
Decr. inhibitions, loss of critical judgment, memory impairment, decr. rxn time
|
0.18-0.30
|
Mental confusion, dizziness, strongly impaired motor skills (slurred speech)
|
0.27-0.40
|
Unable to stand/walk, vomiting, impaired consciousness
|
0.35-0.50
|
Coma and possible death
|
≥0.10
|
Presumptive evidence of driving under influence of alcohol
|
Ethanol (Grain alcohol)
|
Most common abused drug
Ethanol à Acetic acid
Major metabolic pathway:
Ethanol ------(Alcohol Dehydrogenase)------> Acetaldehyde
Testing: Use benzalkonium chloride as antiseptic
|
Methanol (Wood alcohol)
|
Cause blindness
Methanol à Formaldehyde à Formic acid (liver)
|
Isopropanol
(Rubbing alcohol)
|
Liver metabolism:
Isopropanol à Acetone
|
Ethylene glycol
(1,2-ethanediol)
|
Antifreezing agent
Ethylene glycol à Oxalic acid and glycolic acid
(+) Monohydrate calcium oxalate crystals
|
Carbon Monoxide
|
Colorless, odorless, tasteless gas
Has 210x greater affinity than O2 for Hgb
“Cherry-red” color of the face and blood
Specimen: EDTA whole blood
Method: Co-oximetry (HbCO measurement)
|
Cyanide
|
Binds to iron (ferric and ferrous) containing substances like hemoglobin and cytochrome oxidase
“Odor of bitter almonds”
Antidote: Sodium thiosulfate, amyl and sodium nitrite
|
Arsenic
|
“Odor of garlic”
“Metallic taste”
Hair and nails: “Mees lines”
Method: Reinsch test (Flat black)
|
Cadmium
|
Significant environmental pollutant
(+) GGT in urine sample
|
Lead
|
Blocks D-ALA synthase and Ferrocheletase
“Wrist drop or Foot drop” manifestation
Tx: EDTA and dimercaptosuccinic acid (DMA) – remove lead
áFree erythrocyte protoporphyrin
(+) Basophilic stippling (course)
|
Mercury
|
Amalgamate: mix or merge w/ other substances
Specimen:
-Whole blood (organic mercury)
-Urine (inorganic mercury)
Method: Reinsch test (Silvery gray)
|
Drugs of Abuse
|
Opiates
|
Morphine
Codeine
Heroin
Methadone
|
Tranquilizers
|
Diazepam (Valium)
Oxazepam
|
Barbiturates:
Sedative Hypnotics
|
Phenobarbital
Pentobarbital
Amobarbital
|
Dopaminergic pathway stimulants
|
Cocaine
Benzoylecgonine
Amphetamine
|
Hallucinogens
|
Phencyclidine
Lysergic acid diethylamide
Tetrahydrocannabinol
Methaqualone
|
Amphetamines
|
Increase mental alertness (“Uppers”)
MDMA (methylenedioxymethamphetamine) = ecstasy
Methamphetamine HCl = shabu
|
Annabolic steroids
|
Improves athletic performance by increasing muscle mass
|
Cannabinoids
|
Marijuana and hashish
|
Tetrahydrocannabinol (THC)
|
Psycoactive substance of marijuana
Urinary metabolite: 11-nor-deltatetrahydrocannabinol (THC-COOH)
|
Cocaine (Crack)
|
Alkaloid salt
Admin: Insufflation of IV or by inhalation/snorting
Derived from coca plant (erythroxylon)
Cardiac toxicity
Prozac: inhibit the action of cocaine
Urine metabolite: benzoylecgonine
|
Opiates
|
From opium poppy
Heroin
Morphine
Codeine
Methadone
Major metabolites: N-acetylmorphine (heroin) and morphine
Antagonist: Nalaxone (Narcan)
|
Phencyclidine
(Angel dust or angel hair)
|
Hallucinogen
Admin: Ingestion or inhalation
Major metabolite: Phencyclidine HCl
|
Sedative hypnotics
|
Barbiturates (Secobarbital, pentobarbital, Phenobarbital)
Benzodiazopines: Diazepam (Valium), Lorazepam (Ativan), Chlordiazepoxide (Librium)
Major metabolite (barbiturates): Secobarbial
|
Lysergic acid diethylamide (LSD, Lysergide)
|
“Undulating vision”
“Bad trip” – panic reactions
|
Methaqualone (Quaalude)
|
Pyramidal signs (Hypertonicity, hyperreflexia, myoclonus)
|
Vitamins
|
Vitamins
|
Water soluble: B1, B2, B3, B5, B6, B9, B12, Biotin, C, Carnitine
Fat soluble: A, D, E, K
|
Vitamin A
|
CN: Retinol
Def: Night blindness
|
Vitamin E
|
CN: Tocopherol
Def: Mild hemolytic anemia, RBC fragility
|
Vitamin D2
Vitamin D3
|
CN: Ergocalciferol, Cholecalciferol (D2), 1,25-dihydroxycholecalciferol (D3)
Def: Rickets (young), Osteomalacia (adult)
|
Vitamin K
|
CN: Phylloquinones, Menaquinones
Def: Hemorrhage
|
Vitamin B1
|
CN: Thiamine
Def: Beriberi, Wernicke-Korsakoff syndrome
|
Vitamin B2
|
CN: Riboflavin
Def: Angular stomatitis, dermatitis, photophobia
|
Vitamin B3
|
CN: Niacin/Niacinamide/Nicotinic acid/Nicotinamide
Def: Pellagra (dermatitis, disorientation, weight loss)
|
Vitamin B5
|
CN: Panthotenic acid
Def: Depressed immune system, muscle weakness
|
Vitamin B6
|
CN: Pyridoxine, Pyridoxal
Def: Facial seborrhea
|
Vitamin B9
|
CN: Folic acid, Pteroylglutamic acid
Def: Megaloblastic anemia
|
Vitamin B12
|
CN: Cyanocobalamin
Def: Megaloblastic anemia, neurologic abnormalities
|
Vitamin C
|
CN: Ascorbic acid
Def: Scurvy
|
Biotin
|
Def: Dermatitis
|
Carnitine
|
Def: Muscle weakness, fatigue
|